Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27,767,902
-
Number of holders
-
126
-
Total 13F shares, excl. options
-
13,419,466
-
Shares change
-
+363,750
-
Total reported value, excl. options
-
$295,897,870
-
Value change
-
-$1,389,083
-
Put/Call ratio
-
89%
-
Number of buys
-
59
-
Number of sells
-
83
-
Price
-
$22.05
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q2 2016
As of 30 Jun 2016 ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) had 126 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,419,466 shares of stock of the company.
Largest 10 holders included BlackRock Fund Advisors, EAGLE ASSET MANAGEMENT INC, Krensavage Asset Management, LLC, FMR LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, VANGUARD GROUP INC, Fiera Capital Corp, GREAT POINT PARTNERS LLC, and SENZAR ASSET MANAGEMENT, LLC.
This table shows 126 institutional shareholders of the security as of 30 Jun 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.